Home
Conditions
Parkinson Disease

Clinical trial condition

Parkinson Disease

Explore clinical trials studying Parkinson Disease. Study availability and eligibility vary by location and protocol.

3,312 public trials 608 recruiting studies

Refine in advanced search Browse all conditions

Parkinson Disease trial results

Completed

Absorption, Distribution, Metabolism and Excretion of [14C]-Labelled BIA 3-202 and Metabolites

NCT02772614

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Swiss Pharma Contract Ltd Allschwil, Basel, Switzerland

View Trial Details

Completed

Study to Investigate the Tolerability, Steady-state Pharmacokinetics and Erythrocyte COMT Inhibition of BIA 3-202

NCT02772627

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Human Pharmacology Unit - BIAL - Portela & Ca, S.A. S. Mamede Do Coronado, Portugal

View Trial Details

Completed

Resistance Versus Balance Training in Parkinson's Disease

NCT02253563

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Not specified

View Trial Details

Completed

High-intensity Exercise and Fall Prevention Boot Camp for Parkinson's Disease

NCT02230267

Conditions: Basal Ganglia Diseases, Behavior, Brain Diseases, +9 more
Locations: University of Nevada, Las Vegas Las Vegas, Nevada, United States

View Trial Details

Completed

A Study in Healthy Male Volunteers to Investigate a New Drug for the Treatment of Parkinson's Disease

NCT02764892

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Not specified

View Trial Details

Completed

Study to Investigate the Safety, Tolerability, Steady State Pharmacokinetic and Pharmacodynamic Profile of BIA 3-202

NCT02763800

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Guy's Drug Research Unit London, United Kingdom

View Trial Details

Completed

Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Carbidopa (100/25 mg)

NCT02763839

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Human Pharmacology Unit - BIAL - Portela & Ca, S.A. S. Mamede Do Coronado, Portugal

View Trial Details

Completed

Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Benserazide (100/25 mg)

NCT02763852

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Human Pharmacology Unit - BIAL - Portela & Ca, S.A. S. Mamede Do Coronado, Portugal

View Trial Details

Completed

Mapping Mood in the Subthalamic Nucleus in Parkinson's Disease (PD)

NCT00847431

Conditions: Anxiety, Anxiety Disorders, Basal Ganglia Diseases, +13 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

University of Cincinnati, Movement Disorder Center Cincinnati, Ohio, United States

View Trial Details

Completed

Automated Telehealth Diagnostics for Remote Parkinson Monitoring

NCT02152319

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations: University of Rochester Rochester, New York, United States

View Trial Details

Parkinson Disease

Parkinson Disease trial results

Related conditions